Viabahn球囊扩张式覆膜支架在开窗EVAR中作为肾动脉桥接支架的初步结果
本研究前瞻性收集3家意大利大学医院2018至2019年接受开窗腔内主动脉修复(FEVAR)的患者,评估Viabahn球囊扩张式覆膜支架(VBX)作为肾动脉桥接支架的初步结局。26例患者共51条肾动脉计划重建,技术成功率在患者水平为88.5%(23/26)、靶血管水平为94.2%(48/51),随访中无动脉瘤相关死亡和肾功能不全。结论认为VBX作为肾动脉桥接支架安全可行,既往EVAR和肾动脉迂曲可能影响靶血管结局。
要点
- VBX作为FEVAR肾动脉桥接支架技术成功率患者水平88.5%、靶血管水平94.2%。
- 随访中靶动脉不稳定免除率为1个月96.1%、6个月92.3%。
- 既往EVAR和肾动脉迂曲可能是靶血管不良结局的挑战因素。
核心结论
- VBX作为FEVAR中肾动脉桥接支架安全可行。
- 既往EVAR和肾动脉迂曲可能对靶血管命运构成挑战。
研究设计与样本
- 前瞻性收集2018至2019年3家意大利转诊大学医院接受FEVAR的患者。
- 研究期间VBX为肾动脉桥接支架的一线选择。
- 共纳入26例择期FEVAR,包括近肾/肾旁动脉瘤20例、II型胸腹主动脉瘤3例、IV型3例。
- 51条肾动脉计划重建,其中向下32条、水平10条、向上6条、向下+向上4条。
主要发现
- 技术成功在患者水平为88.5%(23/26),在靶血管水平为94.2%(48/51)。
- 30天内发生1例闭塞(2.1%),患者既往有EVAR和肾上固定。
- 随访中位10个月,6个月后发生1例IC型内漏(2.1%),患者为向上+向下动脉走向。
- 靶动脉不稳定免除率1个月为96.1%(CI=0.89至1.04),6个月为92.3%(CI=0.82至1.03)。
- 随访期间无动脉瘤相关死亡和肾功能不全。
关键数值与推荐
- 技术成功定义为开窗支架完全释放且无靶血管丢失、分支狭窄或闭塞及I或III型内漏。
- 靶动脉不稳定定义为靶血管相关死亡、闭塞、破裂或因狭窄、内漏或脱接而再干预。
- 肾动脉构型分类:向上为任何角度>30°高于水平或垂直于主动脉轴的横轴;向下为角度>30°低于横轴;向下+向上为角度<30°且肾动脉成角>90°。
临床怎么用
- 在FEVAR中可将VBX作为肾动脉桥接支架的一线选择。
- 对既往EVAR和肾动脉迂曲患者应加强靶血管随访。
局限性
- 样本量较小(26例患者、51条肾动脉)。
- 随访时间较短(中位10个月)。
- 为初步结果,需更大样本和更长随访验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To report preliminary outcomes of Viabahn Balloon-Expandable Endoprosthesis (VBX) stent-graft as bridging stent for renal arteries in fenestrated endovascular aneurysm repair (FEVAR). MATERIALS AND METHODS: Between 2018 and 2019, patients undergoing FEVAR at 3 referral Italian university hospitals were prospectively collected. During the study period, VBX was the first-line choice as bridging stent for renal arteries. Procedural and anatomical data were analyzed, including renal artery (RA) configuration. A dedicated software (3Mensio, Vascular Imaging, Bilthoeven, The Netherlands) was used and RA anatomy classified as follow: upward-oriented in case of any angle >30° above the horizontal or transverse axis perpendicular to the aortic axis, downward-oriented if there was an angle >30° measured below the transverse axis and downward + upward in case of an angle <30° associated with a renal artery angulation >90°. Primary endpoints were technical success, defined as complete deployment of the fenestrated endograft without target vessel (TV) loss, limb stenosis or occlusion and type I or III endoleak, and freedom from target artery instability (TAI), defined by target vessel-related death, occlusion, rupture or reintervention for stenosis, endoleak or disconnection. Secondary endpoints were target artery patency rate and freedom from reinterventions. RESULTS: A total of 26 elective FEVAR for juxta/pararenal aneurysm (20), thoracoabdominal type II (3) and type IV (3) were included. Fifty-one RA were planned for revascularization. Of these, 32 were downward, 10 horizontal, 6 upward, 4 were downward + upward. Technical success was achieved in 88.5% (23/26) of patients and 94.2% (48/51) of the TVs. One occlusion (2.1%) occurred within 30 days in a patient with previous endovascular aortic repair and suprarenal fixation. During follow-up (median 10 months), there was 1 type IC endoleak after 6 months (2.1%) in a patient with upward plus downward arterial orientation. Freedom from TAI was 96.1% (CI = 0.89 to 1.04) at first month and 92.3% (CI = 0.82 to 1.03) at 6 months. No aneurysm-related mortality and renal insufficiency occurred during follow-up. CONCLUSION: The use of VBX as bridging stent of RA in FEVAR is safe and feasible. Previous EVAR and tortuosity of RA may be a challenging on target vessel fate.
引用
- Mezzetto L, Mastrorilli D, Leone N, et al. Preliminary Outcomes of Viabahn Balloon-Expandable Endoprosthesis as Bridging Stent in Renal Arteries During Fenestrated Endovascular Aortic Repair. J Endovasc Ther. 2021. PMID: 33973493. doi:10.1177/15266028211012403
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。